← All investors
Omega Funds
45 portfolio companies · 3 on the map · $882.6M raised · 3 cities
Portfolio map
3 Omega Funds portfolio companies on the map.
Portfolio companies

Arcutis Biotherapeutics
Westlake Village
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Biotechnology Research$833.5MEst. 2016
NEUROTECH U S A
Cumberland
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.
Biotechnology Research$49.1M- AT
Alveus Therapeutics
Philadelphia
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Biotechnology ResearchSeries AEst. 2023
More portfolio companies
40 more Omega Funds investments we track beyond the map — 45 tracked in total.
NeuroVision ImagingSacramento · Venture
CatalYmPlanegg · Series D
NRG TherapeuticsCambridge · Series B
nChroma BioBoston · Venture
Protego BiopharmaSan Diego · Series B
CinCor PharmaCincinnati · Series B
BBOTPalo Alto · Post-IPO Equity
ARTBIOCambridge · Series B
SynthekineMenlo Park · Series B
Chroma MedicineCambridge · Series B
Antares TherapeuticsBoston · Series A
Spiro MedicalMenlo Park · Series A
Spruce BiosciencesSouth San Francisco · Series B
Marea TherapeuticsSan Francisco · Series B
Arrakis TherapeuticsWaltham · Series B
Replimune GroupWoburn · Series B
Callio TherapeuticsSeattle · Series A
Endeavor BioMedicinesSolana Beach · Series C
XII MedicalUnion City · Series B
Vanqua BioChicago · Series B
EyebiotechNew York · Series A
Anaconda BioMedBarcelona · Series B
Theseus PharmaceuticalsNew York · Series B
IFM TherapeuticsBoston · Venture
HydrocisionNorth Billerica · Venture
Alpine Immune SciencesSeattle · Post-IPO Equity
Chord TherapeuticsGeneva · Series A
Morphic TherapeuticWaltham · Series B
ObsEvaPlan-les-ouates · Post-IPO Equity
Jounce TherapeuticsCambridge · Series B
ThankfulLos Angeles · Series A
AttenuaMountain View · Series A
Kuros BiosciencesSchlieren · Post-IPO Equity
Translate BioLexington · Series C
EgaletWayne · Post-IPO Equity
Eurobio-ScientificEssonnes · Venture
Checkmate PharmaceuticalsCambridge · Series C
ExentaNew York · Venture
Elixir PharmaceuticalsCambridge · Series D
DevelogenGöttingen · Venture
Portfolio map
3 Omega Funds portfolio companies on the map.